Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6536998 | 0.79 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL3257814 | 0.77 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL4102252 | 0.75 | TSHR (0.35) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL1054681 | 0.73 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL16990129 | 0.72 | CA1 (0.36) | — | |
| SCHEMBL27771794 | 0.71 | ALDH1A1 (0.32) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL22072254 | 0.69 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL10020904 | 0.67 | — | — | |
| SCHEMBL28373 | 0.67 | ALDH1A1 (0.60) | ALDH1A1L3MBTL1TSHRTDP1 | |
| SCHEMBL3434802 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162787-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | WARNER-LAMBERT COMPANY LLC | 2003-08-28 | — | — | US | claimed |
| US-20050250815-A1 | Inhibitors of fractor Xa and other serine proteases involved in the coagulation cascade | WARNER-LAMBERT COMPANY LLC | 2005-11-10 | — | — | US | disclosed |
| US-6890855-B2 | Process of removing residue material from a precision surface | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2005-05-10 | — | — | US | disclosed |
| US-20030162787-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | WARNER-LAMBERT COMPANY LLC | 2003-08-28 | — | — | US | disclosed |
| US-20030003762-A1 | Process of removing residue material from a precision surface | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2003-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162787-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | TFPI, F11, F12 | ALDH1A1 2068/4885L3MBTL1 2331/4885TSHR 3185/4885 |
| US-20050250815-A1 | Inhibitors of fractor Xa and other serine proteases involved in the coagulation cascade | F12, TFPI, F11 | ALDH1A1 3666/4885L3MBTL1 2166/4885TSHR 2034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.